SBH
GERN icon

Segall Bryant & Hamill’s Geron GERN Stock Holding History

Segall Bryant & Hamill’s Portfolio GERN Stock Details GERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.74M Sell
4,485,554
-254,494
-5% -$359K 0.07% 303
2026
Q1 		$7.06M Sell
4,740,048
-308,888
-6% -$470K 0.1% 266
2025
Q4 		$6.66M Sell
5,048,936
-286,280
-5% -$359K 0.09% 282
2025
Q3 		$7.31M Sell
5,335,216
-1,856,968
-26% -$2.47M 0.1% 274
2025
Q2 		$10.1M Sell
7,192,184
-234,670
-3% -$333K 0.14% 227
2025
Q1 		$11.8M Sell
7,426,854
-19,421
-0.3% -$47.3K 0.18% 177
2024
Q4 		$26.4M Buy
7,446,275
+3,369,196
+83% +$13.5M 0.36% 77
2024
Q3 		$18.5M Sell
4,077,079
-40,257
-1% -$183K 0.25% 124
2024
Q2 		$17.5M Sell
4,117,336
-331,560
-7% -$1.29M 0.31% 104
2024
Q1 		$14.7M Buy
4,448,896
+29,076
+0.7% +$65.1K 0.28% 131
2023
Q4 		$9.33M Sell
4,419,820
-570,679
-11% -$1.11M 0.18% 194
2023
Q3 		$10.6M Buy
4,990,499
+1,545,711
+45% +$4.2M 0.12% 209
2023
Q2 		$11.1M Buy
+3,444,788
New +$9.8M 0.12% 219

Other funds holding GERN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Segall Bryant & Hamill's GERN Position: Q2 2026 in Review

Segall Bryant & Hamill reduced its Geron (GERN) stake by 5.4% in Q2 2026, selling an estimated $359K and leaving 4,485,554 shares worth $5.74M. The position accounts for 0.07% of the portfolio, ranked #303.

Segall Bryant & Hamill first reported a position in GERN in Q2 2023 and has held it in 13 quarters since. The position peaked at $26.4M in Q4 2024. 259 funds tracked by Wall St. Rank hold GERN as of Q2 2026.

  • Segall Bryant & Hamill held 4,485,554 shares of Geron worth $5.74M as of Q2 2026.
  • Segall Bryant & Hamill sold 254,494 Geron shares in Q2 2026, an estimated $359K.
  • Geron made up 0.07% of Segall Bryant & Hamill's portfolio in Q2 2026, its #303 holding.
  • Segall Bryant & Hamill first reported a position in Geron in Q2 2023 and has held it in 13 quarters since.
  • Segall Bryant & Hamill's Geron position peaked at $26.4M in Q4 2024.
  • 259 funds tracked by Wall St. Rank held Geron as of Q2 2026.

Based on Segall Bryant & Hamill's 13F filing for Q2 2026, filed 12 Aug 2026.